RGD Reference Report - STING is required for host defense against neuropathological West Nile virus infection. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

STING is required for host defense against neuropathological West Nile virus infection.

Authors: McGuckin Wuertz, Kathryn  Treuting, Piper M  Hemann, Emily A  Esser-Nobis, Katharina  Snyder, Annelise G  Graham, Jessica B  Daniels, Brian P  Wilkins, Courtney  Snyder, Jessica M  Voss, Kathleen M  Oberst, Andrew  Lund, Jennifer  Gale, Michael 
Citation: McGuckin Wuertz K, etal., PLoS Pathog. 2019 Aug 15;15(8):e1007899. doi: 10.1371/journal.ppat.1007899. eCollection 2019 Aug.
RGD ID: 39128224
Pubmed: (View Article at PubMed) PMID:31415679
DOI: Full-text: DOI:10.1371/journal.ppat.1007899

West Nile Virus (WNV), an emerging and re-emerging RNA virus, is the leading source of arboviral encephalitic morbidity and mortality in the United States. WNV infections are acutely controlled by innate immunity in peripheral tissues outside of the central nervous system (CNS) but WNV can evade the actions of interferon (IFN) to facilitate CNS invasion, causing encephalitis, encephalomyelitis, and death. Recent studies indicate that STimulator of INterferon Gene (STING), canonically known for initiating a type I IFN production and innate immune response to cytosolic DNA, is required for host defense against neurotropic RNA viruses. We evaluated the role of STING in host defense to control WNV infection and pathology in a murine model of infection. When challenged with WNV, STING knock out (-/-) mice displayed increased morbidity and mortality compared to wild type (WT) mice. Virologic analysis and assessment of STING activation revealed that STING signaling was not required for control of WNV in the spleen nor was WNV sufficient to mediate canonical STING activation in vitro. However, STING-/- mice exhibited a clear trend of increased viral load and virus dissemination in the CNS. We found that STING-/- mice exhibited increased and prolonged neurological signs compared to WT mice. Pathological examination revealed increased lesions, mononuclear cellular infiltration and neuronal death in the CNS of STING-/- mice, with sustained pathology after viral clearance. We found that STING was required in bone marrow derived macrophages for early control of WNV replication and innate immune activation. In vivo, STING-/- mice developed an aberrant T cell response in both the spleen and brain during WNV infection that linked with increased and sustained CNS pathology compared to WT mice. Our findings demonstrate that STING plays a critical role in immune programming for the control of neurotropic WNV infection and CNS disease.



Disease Annotations    

Objects Annotated

Genes (Rattus norvegicus)
Sting1  (stimulator of interferon response cGAMP interactor 1)

Genes (Mus musculus)
Sting1  (stimulator of interferon response cGAMP interactor 1)

Genes (Homo sapiens)
STING1  (stimulator of interferon response cGAMP interactor 1)


Additional Information